Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hahn

Showing results (661-670 of 764) with videos related to

Pageof 77
Sort By:
Elife|July 31, 2018
An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancerJi Li, Peter S Choi, Christine L Chaffer, et al.
Oncotarget|April 9, 2026
CREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancerAllison Makovec, John T Phoenix, Hannah E Bergom, et al.
Science (New York, N.Y.)|February 26, 2016
MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cellsGregory V Kryukov, Frederick H Wilson, Jason R Ruth, et al.
JCI Insight|November 3, 2018
Tumor fraction in cell-free DNA as a biomarker in prostate cancerAtish D Choudhury, Lillian Werner, Edoardo Francini, et al.
Neuro-Oncology|January 14, 2017
A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomasYu Sun, John A Alberta, Catherine Pilarz, et al.
Nature Methods|June 28, 2011
A public genome-scale lentiviral expression library of human ORFsXiaoping Yang, Jesse S Boehm, Xinping Yang, et al.
Nature Communications|April 8, 2026
SMARCB1 missense mutants disrupt SWI/SNF complex stability and remodeling activityGarrett W Cooper, Benjamin P Lee, Won Jun Kim, et al.
Nature Medicine|May 10, 2019
The landscape of cancer cell line metabolismHaoxin Li, Shaoyang Ning, Mahmoud Ghandi, et al.
Elife|November 1, 2017
Correction: KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancerElsa Beyer Krall, Belinda Wang, Diana M Munoz, et al.
Elife|February 2, 2017
KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancerElsa B Krall, Belinda Wang, Diana M Munoz, et al.
Pageof 77

Showing results (661-670 of 764) with videos related to

Sort By:
Pageof 77
Elife|July 31, 2018
An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancerJi Li, Peter S Choi, Christine L Chaffer, et al.
Oncotarget|April 9, 2026
CREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancerAllison Makovec, John T Phoenix, Hannah E Bergom, et al.
Science (New York, N.Y.)|February 26, 2016
MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cellsGregory V Kryukov, Frederick H Wilson, Jason R Ruth, et al.
JCI Insight|November 3, 2018
Tumor fraction in cell-free DNA as a biomarker in prostate cancerAtish D Choudhury, Lillian Werner, Edoardo Francini, et al.
Neuro-Oncology|January 14, 2017
A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomasYu Sun, John A Alberta, Catherine Pilarz, et al.
Nature Methods|June 28, 2011
A public genome-scale lentiviral expression library of human ORFsXiaoping Yang, Jesse S Boehm, Xinping Yang, et al.
Nature Communications|April 8, 2026
SMARCB1 missense mutants disrupt SWI/SNF complex stability and remodeling activityGarrett W Cooper, Benjamin P Lee, Won Jun Kim, et al.
Nature Medicine|May 10, 2019
The landscape of cancer cell line metabolismHaoxin Li, Shaoyang Ning, Mahmoud Ghandi, et al.
Elife|November 1, 2017
Correction: KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancerElsa Beyer Krall, Belinda Wang, Diana M Munoz, et al.
Elife|February 2, 2017
KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancerElsa B Krall, Belinda Wang, Diana M Munoz, et al.
Pageof 77